Klio Pharma Invests 32 Crores API Manufacturing Unit in Telangana

Klio Pharma Private Limited's Khajapur, Medak, Telangana, Active Pharmaceuticals Ingredients (APIs) Manufacturing Unit would boost India's pharmaceutical independence. This project has good prospects with an anticipated 32 Crores (USD 3.8 million) investment and 8350 Kg/Day API output. It intends to reduce India's dependency on foreign APIs, strengthening the pharmaceutical industry and boosting Khajapur and Medak's economy.

The project's goal of creating jobs and boosting the local economy is admirable, but several questions need clarity. The sorts of APIs Klio Pharma would make at this new plant would help assess the project's effect. Maintaining sustainable manufacturing methods requires addressing environmental concerns and following rules. Assessing the social effect on the local community and resolving issues may help build long-term peace and mutual benefit.

Klio Pharma supports India's "Make in India" effort to boost local production and self-sufficiency. Klio Pharma, a new pharmaceutical company, is supporting India's API self-sufficiency objectives as part of its national advancement and pharmaceutical industry.

As on December 2023, The project is currently in the stage of being approved currently awaiting approval from the government.

News by Rahul Yelligetti